Targeting Aging News Today

From a $1 pill that treats diabetes to a mysterious chemical unearthed on Easter Island and stem injections - scientists may be getting close to anti-aging treatments that could soon hit the market.

Researchers at the American Federation for Aging Research are launching the TAME trial, a six-year series of studies aimed to see if cheap diabetes drug Metformin can increase lifespan.

Long speculated to slow or even reverse aging in off-label use, the generic drugs metformin and rapamycin are getting formal clinical trials this year.

Researchers are harnessing basic biology to develop drugs that foster healthy aging. Just don’t call them antiaging pills.

Understanding which genes are involved in healthy aging is the first step to developing effective therapeutics. New research helps fill in the genetic map.

The Buck Institute for Research on Aging is getting ready to launch the first-ever clinical trial on the effects of ketone supplementation on frailty after receiving a $3.5 million grant from the National Institutes of Health.

The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.

Metformin is a first-line medication for type 2 diabetes, with evidence suggesting the drug may promote healthy aging.

Experiments with animals and humans indicate that levels of this amino acid can be increased, which extended life in rodents by the equivalent of eight human years

Increasingly, scientists believe that genes, and not necessarily good habits, determine who lives past 100. But which genes?